nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—CYP2B6—malignant glioma	0.595	1	CbGaD
Carbamazepine—CYP1A2—Carmustine—malignant glioma	0.0885	0.57	CbGbCtD
Carbamazepine—CYP3A4—Temozolomide—malignant glioma	0.0669	0.431	CbGbCtD
Carbamazepine—Pigmentation disorder—Temozolomide—malignant glioma	0.00329	0.0248	CcSEcCtD
Carbamazepine—Paresis—Temozolomide—malignant glioma	0.00301	0.0227	CcSEcCtD
Carbamazepine—Hyperacusis—Temozolomide—malignant glioma	0.00295	0.0222	CcSEcCtD
Carbamazepine—Meningitis—Carmustine—malignant glioma	0.00293	0.0221	CcSEcCtD
Carbamazepine—Azotaemia—Carmustine—malignant glioma	0.00213	0.0161	CcSEcCtD
Carbamazepine—Transaminases increased—Carmustine—malignant glioma	0.00187	0.0141	CcSEcCtD
Carbamazepine—Embolism—Temozolomide—malignant glioma	0.00171	0.0129	CcSEcCtD
Carbamazepine—Digestion impaired—Temozolomide—malignant glioma	0.00164	0.0124	CcSEcCtD
Carbamazepine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00146	0.011	CcSEcCtD
Carbamazepine—Memory impairment—Temozolomide—malignant glioma	0.0014	0.0105	CcSEcCtD
Carbamazepine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00133	0.0101	CcSEcCtD
Carbamazepine—Endocrine disorder—Temozolomide—malignant glioma	0.00132	0.00998	CcSEcCtD
Carbamazepine—Speech disorder—Carmustine—malignant glioma	0.00132	0.00996	CcSEcCtD
Carbamazepine—Accidental injury—Carmustine—malignant glioma	0.00128	0.00968	CcSEcCtD
Carbamazepine—Speech disorder—Temozolomide—malignant glioma	0.00128	0.00962	CcSEcCtD
Carbamazepine—Thinking abnormal—Carmustine—malignant glioma	0.00124	0.00935	CcSEcCtD
Carbamazepine—Drug interaction—Carmustine—malignant glioma	0.00122	0.00923	CcSEcCtD
Carbamazepine—Leukocytosis—Carmustine—malignant glioma	0.00121	0.00911	CcSEcCtD
Carbamazepine—Coordination abnormal—Carmustine—malignant glioma	0.00116	0.00872	CcSEcCtD
Carbamazepine—Hearing impaired—Temozolomide—malignant glioma	0.00115	0.00869	CcSEcCtD
Carbamazepine—Pulmonary embolism—Carmustine—malignant glioma	0.00114	0.00856	CcSEcCtD
Carbamazepine—Coordination abnormal—Temozolomide—malignant glioma	0.00112	0.00843	CcSEcCtD
Carbamazepine—Pulmonary embolism—Temozolomide—malignant glioma	0.0011	0.00828	CcSEcCtD
Carbamazepine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0011	0.00828	CcSEcCtD
Carbamazepine—Depressed level of consciousness—Carmustine—malignant glioma	0.0011	0.00827	CcSEcCtD
Carbamazepine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00106	0.00799	CcSEcCtD
Carbamazepine—Coma—Carmustine—malignant glioma	0.00104	0.00783	CcSEcCtD
Carbamazepine—Aplastic anaemia—Temozolomide—malignant glioma	0.00103	0.00777	CcSEcCtD
Carbamazepine—Gynaecomastia—Carmustine—malignant glioma	0.00102	0.00766	CcSEcCtD
Carbamazepine—Mental disability—Carmustine—malignant glioma	0.000985	0.00743	CcSEcCtD
Carbamazepine—Mental disability—Temozolomide—malignant glioma	0.000952	0.00718	CcSEcCtD
Carbamazepine—Thrombophlebitis—Carmustine—malignant glioma	0.000952	0.00718	CcSEcCtD
Carbamazepine—Swelling—Carmustine—malignant glioma	0.000934	0.00705	CcSEcCtD
Carbamazepine—Ear pain—Temozolomide—malignant glioma	0.000934	0.00704	CcSEcCtD
Carbamazepine—Thrombophlebitis—Temozolomide—malignant glioma	0.00092	0.00694	CcSEcCtD
Carbamazepine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000916	0.00691	CcSEcCtD
Carbamazepine—Injury—Carmustine—malignant glioma	0.000897	0.00676	CcSEcCtD
Carbamazepine—Deafness—Temozolomide—malignant glioma	0.000891	0.00672	CcSEcCtD
Carbamazepine—Vascular purpura—Temozolomide—malignant glioma	0.000891	0.00672	CcSEcCtD
Carbamazepine—Hepatic failure—Temozolomide—malignant glioma	0.000886	0.00668	CcSEcCtD
Carbamazepine—Amnesia—Carmustine—malignant glioma	0.000877	0.00662	CcSEcCtD
Carbamazepine—Amnesia—Temozolomide—malignant glioma	0.000848	0.00639	CcSEcCtD
Carbamazepine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000844	0.00637	CcSEcCtD
Carbamazepine—Hyponatraemia—Carmustine—malignant glioma	0.000828	0.00624	CcSEcCtD
Carbamazepine—Purpura—Temozolomide—malignant glioma	0.000827	0.00623	CcSEcCtD
Carbamazepine—Diplopia—Carmustine—malignant glioma	0.000824	0.00622	CcSEcCtD
Carbamazepine—Diplopia—Temozolomide—malignant glioma	0.000797	0.00601	CcSEcCtD
Carbamazepine—Ataxia—Carmustine—malignant glioma	0.000775	0.00585	CcSEcCtD
Carbamazepine—Liver function test abnormal—Carmustine—malignant glioma	0.000761	0.00574	CcSEcCtD
Carbamazepine—Hypokalaemia—Carmustine—malignant glioma	0.00075	0.00566	CcSEcCtD
Carbamazepine—Ataxia—Temozolomide—malignant glioma	0.000749	0.00565	CcSEcCtD
Carbamazepine—Muscular weakness—Carmustine—malignant glioma	0.000727	0.00548	CcSEcCtD
Carbamazepine—Hypokalaemia—Temozolomide—malignant glioma	0.000725	0.00547	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000717	0.00541	CcSEcCtD
Carbamazepine—Dysphagia—Carmustine—malignant glioma	0.000712	0.00537	CcSEcCtD
Carbamazepine—Muscular weakness—Temozolomide—malignant glioma	0.000703	0.0053	CcSEcCtD
Carbamazepine—Dysphagia—Temozolomide—malignant glioma	0.000689	0.00519	CcSEcCtD
Carbamazepine—Pancytopenia—Carmustine—malignant glioma	0.000677	0.0051	CcSEcCtD
Carbamazepine—Sweating increased—Temozolomide—malignant glioma	0.000671	0.00506	CcSEcCtD
Carbamazepine—Bronchitis—Temozolomide—malignant glioma	0.000662	0.00499	CcSEcCtD
Carbamazepine—Pancytopenia—Temozolomide—malignant glioma	0.000654	0.00493	CcSEcCtD
Carbamazepine—Hyperglycaemia—Carmustine—malignant glioma	0.000643	0.00485	CcSEcCtD
Carbamazepine—Pneumonia—Carmustine—malignant glioma	0.000639	0.00482	CcSEcCtD
Carbamazepine—Pollakiuria—Temozolomide—malignant glioma	0.000636	0.0048	CcSEcCtD
Carbamazepine—Erectile dysfunction—Temozolomide—malignant glioma	0.000634	0.00478	CcSEcCtD
Carbamazepine—Depression—Carmustine—malignant glioma	0.000633	0.00478	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000628	0.00474	CcSEcCtD
Carbamazepine—Weight increased—Temozolomide—malignant glioma	0.000627	0.00473	CcSEcCtD
Carbamazepine—Renal failure—Carmustine—malignant glioma	0.000624	0.00471	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Carmustine—malignant glioma	0.000623	0.0047	CcSEcCtD
Carbamazepine—Hyperglycaemia—Temozolomide—malignant glioma	0.000621	0.00468	CcSEcCtD
Carbamazepine—Stomatitis—Carmustine—malignant glioma	0.000619	0.00467	CcSEcCtD
Carbamazepine—Urinary tract infection—Carmustine—malignant glioma	0.000617	0.00466	CcSEcCtD
Carbamazepine—Pneumonia—Temozolomide—malignant glioma	0.000617	0.00466	CcSEcCtD
Carbamazepine—Infestation NOS—Temozolomide—malignant glioma	0.000614	0.00463	CcSEcCtD
Carbamazepine—Infestation—Temozolomide—malignant glioma	0.000614	0.00463	CcSEcCtD
Carbamazepine—Depression—Temozolomide—malignant glioma	0.000612	0.00462	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000609	0.00459	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000602	0.00454	CcSEcCtD
Carbamazepine—Stomatitis—Temozolomide—malignant glioma	0.000598	0.00451	CcSEcCtD
Carbamazepine—Urinary tract infection—Temozolomide—malignant glioma	0.000597	0.0045	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000581	0.00438	CcSEcCtD
Carbamazepine—Sinusitis—Temozolomide—malignant glioma	0.000576	0.00434	CcSEcCtD
Carbamazepine—Hallucination—Carmustine—malignant glioma	0.000567	0.00428	CcSEcCtD
Carbamazepine—Oedema peripheral—Carmustine—malignant glioma	0.000562	0.00424	CcSEcCtD
Carbamazepine—Connective tissue disorder—Carmustine—malignant glioma	0.00056	0.00423	CcSEcCtD
Carbamazepine—Nepafenac—PTGS1—malignant glioma	0.000556	0.0758	CrCbGaD
Carbamazepine—Hepatitis—Temozolomide—malignant glioma	0.000551	0.00416	CcSEcCtD
Carbamazepine—Hallucination—Temozolomide—malignant glioma	0.000548	0.00414	CcSEcCtD
Carbamazepine—Pharyngitis—Temozolomide—malignant glioma	0.000547	0.00412	CcSEcCtD
Carbamazepine—Urinary tract disorder—Temozolomide—malignant glioma	0.000544	0.0041	CcSEcCtD
Carbamazepine—Magnesium salicylate—PTGS1—malignant glioma	0.000543	0.0741	CrCbGaD
Carbamazepine—Oedema peripheral—Temozolomide—malignant glioma	0.000543	0.00409	CcSEcCtD
Carbamazepine—Connective tissue disorder—Temozolomide—malignant glioma	0.000542	0.00408	CcSEcCtD
Carbamazepine—Urethral disorder—Temozolomide—malignant glioma	0.00054	0.00407	CcSEcCtD
Carbamazepine—Eye disorder—Carmustine—malignant glioma	0.000533	0.00402	CcSEcCtD
Carbamazepine—Flushing—Carmustine—malignant glioma	0.000529	0.00399	CcSEcCtD
Carbamazepine—Epinastine—CYP2B6—malignant glioma	0.000528	0.0721	CrCbGaD
Carbamazepine—Erythema multiforme—Temozolomide—malignant glioma	0.000521	0.00393	CcSEcCtD
Carbamazepine—Eye disorder—Temozolomide—malignant glioma	0.000515	0.00388	CcSEcCtD
Carbamazepine—Tinnitus—Temozolomide—malignant glioma	0.000514	0.00387	CcSEcCtD
Carbamazepine—Flushing—Temozolomide—malignant glioma	0.000511	0.00386	CcSEcCtD
Carbamazepine—Cardiac disorder—Temozolomide—malignant glioma	0.000511	0.00386	CcSEcCtD
Carbamazepine—Arrhythmia—Carmustine—malignant glioma	0.000509	0.00384	CcSEcCtD
Carbamazepine—Alopecia—Carmustine—malignant glioma	0.000504	0.0038	CcSEcCtD
Carbamazepine—Angiopathy—Temozolomide—malignant glioma	0.0005	0.00377	CcSEcCtD
Carbamazepine—Mental disorder—Carmustine—malignant glioma	0.0005	0.00377	CcSEcCtD
Carbamazepine—Immune system disorder—Temozolomide—malignant glioma	0.000498	0.00375	CcSEcCtD
Carbamazepine—Mediastinal disorder—Temozolomide—malignant glioma	0.000497	0.00375	CcSEcCtD
Carbamazepine—Erythema—Carmustine—malignant glioma	0.000496	0.00374	CcSEcCtD
Carbamazepine—Malnutrition—Carmustine—malignant glioma	0.000496	0.00374	CcSEcCtD
Carbamazepine—Chills—Temozolomide—malignant glioma	0.000494	0.00373	CcSEcCtD
Carbamazepine—Alopecia—Temozolomide—malignant glioma	0.000487	0.00367	CcSEcCtD
Carbamazepine—Mental disorder—Temozolomide—malignant glioma	0.000483	0.00364	CcSEcCtD
Carbamazepine—Back pain—Carmustine—malignant glioma	0.00048	0.00362	CcSEcCtD
Carbamazepine—Malnutrition—Temozolomide—malignant glioma	0.00048	0.00362	CcSEcCtD
Carbamazepine—Erythema—Temozolomide—malignant glioma	0.00048	0.00362	CcSEcCtD
Carbamazepine—Dysgeusia—Temozolomide—malignant glioma	0.00047	0.00354	CcSEcCtD
Carbamazepine—Vision blurred—Carmustine—malignant glioma	0.000468	0.00353	CcSEcCtD
Carbamazepine—Tremor—Carmustine—malignant glioma	0.000465	0.00351	CcSEcCtD
Carbamazepine—Back pain—Temozolomide—malignant glioma	0.000464	0.0035	CcSEcCtD
Carbamazepine—Salsalate—PTGS1—malignant glioma	0.000462	0.063	CrCbGaD
Carbamazepine—Oxaprozin—PTGS1—malignant glioma	0.000462	0.063	CrCbGaD
Carbamazepine—Anaemia—Carmustine—malignant glioma	0.000459	0.00346	CcSEcCtD
Carbamazepine—Agitation—Carmustine—malignant glioma	0.000456	0.00344	CcSEcCtD
Carbamazepine—Vision blurred—Temozolomide—malignant glioma	0.000452	0.00341	CcSEcCtD
Carbamazepine—Tremor—Temozolomide—malignant glioma	0.000449	0.00339	CcSEcCtD
Carbamazepine—Leukopenia—Carmustine—malignant glioma	0.000444	0.00335	CcSEcCtD
Carbamazepine—Anaemia—Temozolomide—malignant glioma	0.000443	0.00334	CcSEcCtD
Carbamazepine—Agitation—Temozolomide—malignant glioma	0.000441	0.00332	CcSEcCtD
Carbamazepine—Angioedema—Temozolomide—malignant glioma	0.000438	0.00331	CcSEcCtD
Carbamazepine—Phenytoin—CYP2C18—malignant glioma	0.000434	0.0593	CrCbGaD
Carbamazepine—Vertigo—Temozolomide—malignant glioma	0.000431	0.00325	CcSEcCtD
Carbamazepine—Convulsion—Carmustine—malignant glioma	0.00043	0.00324	CcSEcCtD
Carbamazepine—Leukopenia—Temozolomide—malignant glioma	0.000429	0.00324	CcSEcCtD
Carbamazepine—Hypertension—Carmustine—malignant glioma	0.000429	0.00323	CcSEcCtD
Carbamazepine—Chest pain—Carmustine—malignant glioma	0.000423	0.00319	CcSEcCtD
Carbamazepine—Myalgia—Carmustine—malignant glioma	0.000423	0.00319	CcSEcCtD
Carbamazepine—Anxiety—Carmustine—malignant glioma	0.000421	0.00318	CcSEcCtD
Carbamazepine—Convulsion—Temozolomide—malignant glioma	0.000416	0.00313	CcSEcCtD
Carbamazepine—Hypertension—Temozolomide—malignant glioma	0.000414	0.00312	CcSEcCtD
Carbamazepine—Confusional state—Carmustine—malignant glioma	0.000409	0.00308	CcSEcCtD
Carbamazepine—Myalgia—Temozolomide—malignant glioma	0.000408	0.00308	CcSEcCtD
Carbamazepine—Arthralgia—Temozolomide—malignant glioma	0.000408	0.00308	CcSEcCtD
Carbamazepine—Anxiety—Temozolomide—malignant glioma	0.000407	0.00307	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000406	0.00306	CcSEcCtD
Carbamazepine—Oedema—Carmustine—malignant glioma	0.000405	0.00306	CcSEcCtD
Carbamazepine—Infection—Carmustine—malignant glioma	0.000403	0.00304	CcSEcCtD
Carbamazepine—Dry mouth—Temozolomide—malignant glioma	0.000399	0.00301	CcSEcCtD
Carbamazepine—Thrombocytopenia—Carmustine—malignant glioma	0.000397	0.00299	CcSEcCtD
Carbamazepine—Ethopropazine—BCHE—malignant glioma	0.000396	0.054	CrCbGaD
Carbamazepine—Tachycardia—Carmustine—malignant glioma	0.000395	0.00298	CcSEcCtD
Carbamazepine—Confusional state—Temozolomide—malignant glioma	0.000395	0.00298	CcSEcCtD
Carbamazepine—Anaphylactic shock—Temozolomide—malignant glioma	0.000392	0.00295	CcSEcCtD
Carbamazepine—Oedema—Temozolomide—malignant glioma	0.000392	0.00295	CcSEcCtD
Carbamazepine—Infection—Temozolomide—malignant glioma	0.000389	0.00293	CcSEcCtD
Carbamazepine—Anorexia—Carmustine—malignant glioma	0.000386	0.00291	CcSEcCtD
Carbamazepine—Nervous system disorder—Temozolomide—malignant glioma	0.000384	0.0029	CcSEcCtD
Carbamazepine—Thrombocytopenia—Temozolomide—malignant glioma	0.000383	0.00289	CcSEcCtD
Carbamazepine—Skin disorder—Temozolomide—malignant glioma	0.00038	0.00287	CcSEcCtD
Carbamazepine—Hypotension—Carmustine—malignant glioma	0.000379	0.00286	CcSEcCtD
Carbamazepine—Hyperhidrosis—Temozolomide—malignant glioma	0.000379	0.00285	CcSEcCtD
Carbamazepine—Anorexia—Temozolomide—malignant glioma	0.000373	0.00281	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000369	0.00278	CcSEcCtD
Carbamazepine—Insomnia—Carmustine—malignant glioma	0.000366	0.00276	CcSEcCtD
Carbamazepine—Paraesthesia—Carmustine—malignant glioma	0.000364	0.00274	CcSEcCtD
Carbamazepine—Modafinil—CYP2B6—malignant glioma	0.000363	0.0496	CrCbGaD
Carbamazepine—Dyspnoea—Carmustine—malignant glioma	0.000361	0.00272	CcSEcCtD
Carbamazepine—Somnolence—Carmustine—malignant glioma	0.00036	0.00272	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000357	0.00269	CcSEcCtD
Carbamazepine—Insomnia—Temozolomide—malignant glioma	0.000354	0.00267	CcSEcCtD
Carbamazepine—Decreased appetite—Carmustine—malignant glioma	0.000352	0.00266	CcSEcCtD
Carbamazepine—Paraesthesia—Temozolomide—malignant glioma	0.000352	0.00265	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00035	0.00264	CcSEcCtD
Carbamazepine—Dyspnoea—Temozolomide—malignant glioma	0.000349	0.00263	CcSEcCtD
Carbamazepine—Somnolence—Temozolomide—malignant glioma	0.000348	0.00262	CcSEcCtD
Carbamazepine—Constipation—Carmustine—malignant glioma	0.000346	0.00261	CcSEcCtD
Carbamazepine—Pain—Carmustine—malignant glioma	0.000346	0.00261	CcSEcCtD
Carbamazepine—Dyspepsia—Temozolomide—malignant glioma	0.000345	0.0026	CcSEcCtD
Carbamazepine—Decreased appetite—Temozolomide—malignant glioma	0.00034	0.00257	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000338	0.00255	CcSEcCtD
Carbamazepine—Fatigue—Temozolomide—malignant glioma	0.000338	0.00255	CcSEcCtD
Carbamazepine—Constipation—Temozolomide—malignant glioma	0.000335	0.00252	CcSEcCtD
Carbamazepine—Pain—Temozolomide—malignant glioma	0.000335	0.00252	CcSEcCtD
Carbamazepine—Feeling abnormal—Carmustine—malignant glioma	0.000334	0.00252	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Carmustine—malignant glioma	0.000331	0.0025	CcSEcCtD
Carbamazepine—Feeling abnormal—Temozolomide—malignant glioma	0.000323	0.00243	CcSEcCtD
Carbamazepine—Phenytoin—CYP2B6—malignant glioma	0.000322	0.044	CrCbGaD
Carbamazepine—Body temperature increased—Carmustine—malignant glioma	0.00032	0.00242	CcSEcCtD
Carbamazepine—Abdominal pain—Carmustine—malignant glioma	0.00032	0.00242	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00032	0.00241	CcSEcCtD
Carbamazepine—Nepafenac—PTGS2—malignant glioma	0.000318	0.0433	CrCbGaD
Carbamazepine—Urticaria—Temozolomide—malignant glioma	0.000311	0.00235	CcSEcCtD
Carbamazepine—Magnesium salicylate—PTGS2—malignant glioma	0.00031	0.0424	CrCbGaD
Carbamazepine—Modafinil—SLC6A3—malignant glioma	0.00031	0.0423	CrCbGaD
Carbamazepine—Body temperature increased—Temozolomide—malignant glioma	0.00031	0.00233	CcSEcCtD
Carbamazepine—Abdominal pain—Temozolomide—malignant glioma	0.00031	0.00233	CcSEcCtD
Carbamazepine—Desipramine—CYP2C18—malignant glioma	0.000303	0.0413	CrCbGaD
Carbamazepine—Hypersensitivity—Carmustine—malignant glioma	0.000299	0.00225	CcSEcCtD
Carbamazepine—Asthenia—Carmustine—malignant glioma	0.000291	0.00219	CcSEcCtD
Carbamazepine—Hypersensitivity—Temozolomide—malignant glioma	0.000288	0.00218	CcSEcCtD
Carbamazepine—Asthenia—Temozolomide—malignant glioma	0.000281	0.00212	CcSEcCtD
Carbamazepine—Diarrhoea—Carmustine—malignant glioma	0.000277	0.00209	CcSEcCtD
Carbamazepine—Pruritus—Temozolomide—malignant glioma	0.000277	0.00209	CcSEcCtD
Carbamazepine—Dizziness—Carmustine—malignant glioma	0.000268	0.00202	CcSEcCtD
Carbamazepine—Diarrhoea—Temozolomide—malignant glioma	0.000268	0.00202	CcSEcCtD
Carbamazepine—Salsalate—PTGS2—malignant glioma	0.000264	0.036	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—malignant glioma	0.000264	0.036	CrCbGaD
Carbamazepine—Dizziness—Temozolomide—malignant glioma	0.000259	0.00195	CcSEcCtD
Carbamazepine—Vomiting—Carmustine—malignant glioma	0.000258	0.00194	CcSEcCtD
Carbamazepine—Imipramine—CYP2C18—malignant glioma	0.000257	0.0351	CrCbGaD
Carbamazepine—Rash—Carmustine—malignant glioma	0.000255	0.00193	CcSEcCtD
Carbamazepine—Dermatitis—Carmustine—malignant glioma	0.000255	0.00192	CcSEcCtD
Carbamazepine—Headache—Carmustine—malignant glioma	0.000254	0.00191	CcSEcCtD
Carbamazepine—Vomiting—Temozolomide—malignant glioma	0.000249	0.00188	CcSEcCtD
Carbamazepine—Promethazine—CYP2B6—malignant glioma	0.000247	0.0338	CrCbGaD
Carbamazepine—Rash—Temozolomide—malignant glioma	0.000247	0.00186	CcSEcCtD
Carbamazepine—Dermatitis—Temozolomide—malignant glioma	0.000247	0.00186	CcSEcCtD
Carbamazepine—Headache—Temozolomide—malignant glioma	0.000245	0.00185	CcSEcCtD
Carbamazepine—Nausea—Carmustine—malignant glioma	0.000241	0.00181	CcSEcCtD
Carbamazepine—Nausea—Temozolomide—malignant glioma	0.000233	0.00175	CcSEcCtD
Carbamazepine—Desipramine—CYP2B6—malignant glioma	0.000225	0.0307	CrCbGaD
Carbamazepine—Trimipramine—SLC6A3—malignant glioma	0.000219	0.0299	CrCbGaD
Carbamazepine—Desipramine—SLC6A3—malignant glioma	0.000192	0.0261	CrCbGaD
Carbamazepine—Imipramine—CYP2B6—malignant glioma	0.000191	0.026	CrCbGaD
Carbamazepine—Imipramine—SLC6A3—malignant glioma	0.000162	0.0222	CrCbGaD
Carbamazepine—CYP2C8—Metabolism—IDH2—malignant glioma	2.06e-05	0.000188	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—IDH1—malignant glioma	2.05e-05	0.000187	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—STAT3—malignant glioma	2.04e-05	0.000187	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS1—malignant glioma	2.03e-05	0.000186	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SPHK1—malignant glioma	2.03e-05	0.000185	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NCOR1—malignant glioma	2.02e-05	0.000185	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.99e-05	0.000182	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.99e-05	0.000182	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.99e-05	0.000182	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.98e-05	0.000181	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SPHK1—malignant glioma	1.98e-05	0.000181	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.94e-05	0.000178	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP2C18—malignant glioma	1.94e-05	0.000177	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP2B6—malignant glioma	1.94e-05	0.000177	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—malignant glioma	1.9e-05	0.000173	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ASMT—malignant glioma	1.89e-05	0.000173	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—BCHE—malignant glioma	1.89e-05	0.000173	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—SLC5A5—malignant glioma	1.87e-05	0.000171	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—malignant glioma	1.86e-05	0.00017	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.85e-05	0.000169	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—IDH2—malignant glioma	1.84e-05	0.000168	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.8e-05	0.000165	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—IDH2—malignant glioma	1.8e-05	0.000164	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BCAN—malignant glioma	1.78e-05	0.000163	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—IDH1—malignant glioma	1.77e-05	0.000162	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KRAS—malignant glioma	1.75e-05	0.00016	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.73e-05	0.000159	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.73e-05	0.000158	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—COX8A—malignant glioma	1.72e-05	0.000157	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SPHK1—malignant glioma	1.71e-05	0.000157	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP2B6—malignant glioma	1.69e-05	0.000154	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.68e-05	0.000154	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—IDH2—malignant glioma	1.68e-05	0.000153	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.66e-05	0.000151	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CAV1—malignant glioma	1.65e-05	0.000151	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—AKT1—malignant glioma	1.63e-05	0.000149	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.62e-05	0.000148	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PIK3CA—malignant glioma	1.61e-05	0.000147	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTT1—malignant glioma	1.6e-05	0.000147	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.58e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—IDH1—malignant glioma	1.58e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.58e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.58e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTT1—malignant glioma	1.57e-05	0.000143	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—malignant glioma	1.56e-05	0.000142	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—IDH1—malignant glioma	1.54e-05	0.000141	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.54e-05	0.000141	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.53e-05	0.00014	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SPHK1—malignant glioma	1.53e-05	0.00014	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GSTP1—malignant glioma	1.5e-05	0.000138	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS1—malignant glioma	1.5e-05	0.000137	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CG—malignant glioma	1.5e-05	0.000137	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.5e-05	0.000137	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SPHK1—malignant glioma	1.49e-05	0.000137	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS1—malignant glioma	1.47e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CAT—malignant glioma	1.46e-05	0.000134	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP2C18—malignant glioma	1.46e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ASMT—malignant glioma	1.46e-05	0.000133	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—malignant glioma	1.45e-05	0.000133	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.44e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—IDH1—malignant glioma	1.44e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—IDH2—malignant glioma	1.43e-05	0.000131	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.41e-05	0.000129	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.41e-05	0.000129	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—BCHE—malignant glioma	1.4e-05	0.000128	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SPHK1—malignant glioma	1.4e-05	0.000128	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.39e-05	0.000127	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NCOR1—malignant glioma	1.38e-05	0.000126	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.38e-05	0.000126	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BCAN—malignant glioma	1.37e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.37e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—BCHE—malignant glioma	1.37e-05	0.000125	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.36e-05	0.000124	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTT1—malignant glioma	1.36e-05	0.000124	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.35e-05	0.000124	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.35e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.35e-05	0.000123	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CD—malignant glioma	1.32e-05	0.000121	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—malignant glioma	1.32e-05	0.00012	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.29e-05	0.000118	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.29e-05	0.000118	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS1—malignant glioma	1.27e-05	0.000116	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.27e-05	0.000116	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.24e-05	0.000114	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—IDH1—malignant glioma	1.23e-05	0.000113	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTT1—malignant glioma	1.21e-05	0.000111	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SPHK1—malignant glioma	1.19e-05	0.000109	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTT1—malignant glioma	1.18e-05	0.000108	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—BCHE—malignant glioma	1.18e-05	0.000108	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.17e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.17e-05	0.000107	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.17e-05	0.000107	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CB—malignant glioma	1.15e-05	0.000105	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.15e-05	0.000105	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—malignant glioma	1.14e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS1—malignant glioma	1.14e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.13e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.13e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CAV1—malignant glioma	1.13e-05	0.000103	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.11e-05	0.000102	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS1—malignant glioma	1.11e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—IDH2—malignant glioma	1.11e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTT1—malignant glioma	1.11e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.11e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.1e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.1e-05	0.0001	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTP1—malignant glioma	1.09e-05	9.94e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CAT—malignant glioma	1.08e-05	9.9e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CAT—malignant glioma	1.06e-05	9.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—BCHE—malignant glioma	1.06e-05	9.66e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.04e-05	9.54e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.04e-05	9.51e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS1—malignant glioma	1.04e-05	9.47e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.03e-05	9.44e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—BCHE—malignant glioma	1.03e-05	9.43e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.03e-05	9.38e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NCOR1—malignant glioma	1.02e-05	9.35e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SLC5A5—malignant glioma	1.02e-05	9.31e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1e-05	9.17e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NCOR1—malignant glioma	9.99e-06	9.13e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—malignant glioma	9.94e-06	9.09e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—malignant glioma	9.9e-06	9.06e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.87e-06	9.02e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.78e-06	8.94e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.68e-06	8.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—BCHE—malignant glioma	9.63e-06	8.81e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.55e-06	8.73e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SLC5A5—malignant glioma	9.51e-06	8.7e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—IDH1—malignant glioma	9.51e-06	8.7e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTT1—malignant glioma	9.45e-06	8.64e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTP1—malignant glioma	9.42e-06	8.61e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.38e-06	8.58e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SPHK1—malignant glioma	9.2e-06	8.41e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CAT—malignant glioma	9.16e-06	8.38e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CD—malignant glioma	9.02e-06	8.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.02e-06	8.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9e-06	8.23e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.91e-06	8.15e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS1—malignant glioma	8.85e-06	8.09e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.82e-06	8.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NCOR1—malignant glioma	8.65e-06	7.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.53e-06	7.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTP1—malignant glioma	8.4e-06	7.68e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CAV1—malignant glioma	8.33e-06	7.62e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BCHE—malignant glioma	8.23e-06	7.53e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTP1—malignant glioma	8.2e-06	7.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CAT—malignant glioma	8.18e-06	7.48e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CAV1—malignant glioma	8.14e-06	7.45e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.13e-06	7.43e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CAT—malignant glioma	7.98e-06	7.3e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CB—malignant glioma	7.86e-06	7.19e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—malignant glioma	7.79e-06	7.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.77e-06	7.11e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NCOR1—malignant glioma	7.72e-06	7.06e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.69e-06	7.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTP1—malignant glioma	7.66e-06	7.01e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.62e-06	6.97e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—malignant glioma	7.59e-06	6.94e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NCOR1—malignant glioma	7.54e-06	6.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CAT—malignant glioma	7.46e-06	6.82e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.42e-06	6.78e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—malignant glioma	7.32e-06	6.7e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.29e-06	6.67e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—malignant glioma	7.16e-06	6.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CAV1—malignant glioma	7.05e-06	6.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NCOR1—malignant glioma	7.04e-06	6.44e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—malignant glioma	7.01e-06	6.41e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS1—malignant glioma	6.83e-06	6.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—malignant glioma	6.79e-06	6.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.74e-06	6.16e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CD—malignant glioma	6.67e-06	6.1e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.64e-06	6.07e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTP1—malignant glioma	6.55e-06	5.99e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.52e-06	5.96e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—malignant glioma	6.43e-06	5.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CAT—malignant glioma	6.37e-06	5.83e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BCHE—malignant glioma	6.35e-06	5.81e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CAV1—malignant glioma	6.3e-06	5.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.27e-06	5.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—malignant glioma	6.2e-06	5.67e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CAV1—malignant glioma	6.15e-06	5.62e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NCOR1—malignant glioma	6.02e-06	5.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.02e-06	5.5e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.82e-06	5.32e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—malignant glioma	5.76e-06	5.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CAV1—malignant glioma	5.74e-06	5.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.74e-06	5.24e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—malignant glioma	5.73e-06	5.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CB—malignant glioma	5.68e-06	5.2e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CD—malignant glioma	5.65e-06	5.16e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—malignant glioma	5.63e-06	5.15e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—malignant glioma	5.6e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—malignant glioma	5.54e-06	5.06e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.48e-06	5.01e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—malignant glioma	5.4e-06	4.94e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.23e-06	4.78e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.05e-06	4.62e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—malignant glioma	5.05e-06	4.61e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.04e-06	4.61e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—malignant glioma	5.03e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.92e-06	4.5e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CD—malignant glioma	4.92e-06	4.5e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CAT—malignant glioma	4.92e-06	4.5e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—malignant glioma	4.91e-06	4.49e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CAV1—malignant glioma	4.91e-06	4.49e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—malignant glioma	4.88e-06	4.46e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.79e-06	4.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.69e-06	4.29e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.64e-06	4.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.6e-06	4.2e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.47e-06	4.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.39e-06	4.02e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.35e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—malignant glioma	4.31e-06	3.94e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CB—malignant glioma	4.29e-06	3.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—malignant glioma	4.25e-06	3.89e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—malignant glioma	4.25e-06	3.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.01e-06	3.66e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.97e-06	3.63e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.93e-06	3.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—malignant glioma	3.92e-06	3.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—malignant glioma	3.8e-06	3.47e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CAV1—malignant glioma	3.79e-06	3.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—malignant glioma	3.71e-06	3.39e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.55e-06	3.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.47e-06	3.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—malignant glioma	3.46e-06	3.17e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.45e-06	3.15e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.42e-06	3.13e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—malignant glioma	3.39e-06	3.1e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—malignant glioma	3.33e-06	3.04e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.03e-06	2.77e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—malignant glioma	3e-06	2.74e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—malignant glioma	2.96e-06	2.71e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—malignant glioma	2.9e-06	2.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—malignant glioma	2.83e-06	2.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.68e-06	2.45e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.64e-06	2.42e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.62e-06	2.39e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—malignant glioma	2.61e-06	2.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—malignant glioma	2.45e-06	2.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.44e-06	2.23e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—malignant glioma	2.28e-06	2.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—malignant glioma	2.19e-06	2e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—malignant glioma	2.14e-06	1.95e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.09e-06	1.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—malignant glioma	2e-06	1.82e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—malignant glioma	1.71e-06	1.56e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.61e-06	1.47e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—malignant glioma	1.32e-06	1.2e-05	CbGpPWpGaD
